Aiganym Tussipova

Ms. Aiganym Tussipova

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
LKLespek Kutumbetov
Lespek Kutumbetov
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
ATAiganym Tussipova
Aiganym Tussipova
GZGulzhan Zhapparova
Gulzhan Zhapparova
ТТТалшын Муратовна Тленчиева
Талшын Муратовна Тленчиева
AKAslan Kerimbayev
Aslan Kerimbayev
The research conducted in this preclinical study assesses QazCovid-live, a live attenuated COVID-19 vaccine created in Kazakhstan, by conducting preclinical evaluations of safety, immunogenicity, and allergenicity in various animal models, including mice, rats, hamsters, and guinea pigs. The vaccine, developed by attenuating SARS-CoV-2 via numerous Vero cell passages, had no significant adverse effects in acute and subacute toxicity assessments, even at elevated dosages. Allergenicity testing indicated the absence of both immediate and delayed hypersensitivity reactions. Immunogenicity evaluations revealed strong virus-neutralizing antibody responses, especially following intranasal and intratracheal delivery. Studies on reversibility and transmission further validated the vaccine’s stability and non-pathogenicity. The data indicate that QazCovid-live is safe, immunogenic, and prepared for clinical trials, presenting a potential strategy for COVID-19 prevention.

9 September 2025 in Viruses
Verified
Journal Article
Open access
PDF file
LKLespek Kutumbetov
Lespek Kutumbetov
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
ATAiganym Tussipova
Aiganym Tussipova
GZGulzhan Zhapparova
Gulzhan Zhapparova
KBKarina Bisenbayeva
Karina Bisenbayeva
Kuandyk ZhugunissovKuandyk Zhugunissov
Kuandyk Zhugunissov
Peste des petits ruminants (PPR) is an extremely contagious viral disease that significantly affects the health of small ruminants and the economies of livestock, particularly in areas adjacent to endemic regions. This study focused on assessing the vulnerability of different domestic and wild animal species in Kazakhstan, which includes local sheep and goats, African Cameroon goats, saigas, calves, and ground squirrels, to infection by the PPR virus (PPRV). Experimental infections used a virulent strain of PPRV (Nigeria 76/1), with animals being monitored over a period of 21–28 days to evaluate clinical signs, pathological lesions, and viral dissemination. The manifestation of disease differed across species, breed, and age. In Cameroon, goats and saigas displayed severe illness with a mortality rate of 100% and elevated virus levels in key organs, whereas local sheep and goats presented age-related subacute, abortive, and latent manifestations. Calves exhibited mild, subclinical infections, while ground squirrels showed no susceptibility. Viral shedding was observed in the secretions of infected animals, with transmission occurring through airborne and alimentary pathways. No virus carriage was detected in the animals that had recovered. The investigation emphasizes the notable variations in PPRV pathogenesis and transmission risk among different species, highlighting the necessity for focused surveillance and control strategies to avert incursions in PPR-free areas like Kazakhstan.

31 May 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
LKLespek Kutumbetov
Lespek Kutumbetov
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
ATAiganym Tussipova
Aiganym Tussipova
GZGulzhan Zhapparova
Gulzhan Zhapparova
ТТТалшын Муратовна Тленчиева
Талшын Муратовна Тленчиева
AKAslan Kerimbayev
Aslan Kerimbayev
Background/Objectives: Equine rhinopneumonia, caused by equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), continues to be a significant health and economic concern in the global equine industry, particularly in Kazakhstan. While vaccines targeting EHV-1 are available, there is currently no licensed monovalent vaccine for EHV-4, and existing formulations offer limited protection against this serotype. This study aimed to develop and evaluate a freeze-dried, live-attenuated EHV-4 vaccine with improved safety, stability, and immunogenicity. Methods: A field isolate of EHV-4 was attenuated through serial passaging in primary lamb testicle (LT-KK49) cell cultures. Viral biomass was concentrated and formulated with various stabilizers before freeze-drying. The most effective stabilizer composition—sucrose, gelatin, and lactalbumin hydrolysate—was selected based on viral titer retention. Safety and immunogenicity were assessed in mice, guinea pigs, rabbits, donkeys, and horses. A guinea pig reproductive challenge model was used to evaluate protective efficacy. Results: The optimized lyophilized vaccine retained infectivity (>6.0 log10 TCID50/cm3) for at least six months at 4 °C. No adverse clinical signs were observed in any test species. Immunization induced robust neutralizing antibody responses in both small animals and equines. In the guinea pig model, vaccinated females demonstrated 100% pregnancy retention and fetal viability following challenge with a virulent EHV-4 strain. Conclusions: This freeze-dried, live-attenuated EHV-4 vaccine candidate is safe, immunogenic, and thermostable. It offers a promising platform for the targeted prevention of EHV-4 infection, particularly in young horses and in regions with limited cold-chain infrastructure.

12 November 2024 in Eurasian Journal of Applied Biotechnology
Verified
Journal Article
Open access
PDF file
BMBalzhan Shaizadayevna Myrzakhmetova
Balzhan Shaizadayevna Myrzakhmetova
GZGulzhan Zhapparova
Gulzhan Zhapparova
ТТТалшын Муратовна Тленчиева
Талшын Муратовна Тленчиева
KBKarina Bisenbayeva
Karina Bisenbayeva
ATAiganym Tussipova
Aiganym Tussipova
LKLespek Kutumbetov
Lespek Kutumbetov
The territory of the Republic of Kazakhstan is unfavorable for a number of infectious diseases of animals and humans that pose an enzootic biological threat. Such nosological units include anthrax, blackleg, rabies, leukemia, brucellosis, tuberculosis, pasteurellosis, sheep pox, camel pox, CCHF, highly pathogenic avian influenza, foot-and-mouth disease, tick-borne encephalitis, influenza A and B, infectious hepatitis, Newcastle disease, seasonal flu, coronavirus infection COVID-19, etc., some of which affect only animals or humans, and some affect both animals and humans. While some of these diseases are natural focal and pose a constant biological threat, others appear from time to time, penetrating from neighboring countries or develop as a result of movement from the wild - reservoirs and hidden carriers of pathogens. A number of exotic diseases pose a real threat of penetration from outside the country due to interstate movements of people, animals, feed and animal products.

25 August 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
ANAidar Namet
Aidar Namet
MOMukhit B. Orynbayev
Mukhit B. Orynbayev
TDTimur Davlyatshin
Timur Davlyatshin
KSKulyaisan Sultankulova
Kulyaisan Sultankulova
AMAsylzhan Aidaruly Myrzakhmet
Asylzhan Aidaruly Myrzakhmet
BKBerik Khairullin
Berik Khairullin
Background. Stool microscopy and anti-Ascaris IgG serology assess different, but related biological domains. Joint interpretation can identify immunological exposure and intestinal egg shedding without assuming one or both markers are a measure of current infection independently. Objective. To develop a four-pattern paired-marker framework for anti-A. lumbricoides IgG and copromicroscopy results from adults in Kazakhstan and to assess the qualitative analytical concordance of two IgG enzyme-linked immunosorbent assays (ELISAs). Methods. The cross-sectional field study involved 1000 adult volunteers from Almaty and the region providing matched serum and stool samples. Sera were tested by MVA Group indirect anti-Ascaris IgG ELISA, and stool samples were examined by the Kato–Katz and Fülleborn methods. The binary outcome was classified into four pair patterns. All sera were further tested with a commercial ELISA (DRG), and qualitative concordance was calculated. Results. Anti-Ascaris IgG was found in 331 of the 1000 subjects (33.1%; 95% CI, 30.3–36.1%), while A. lumbricoides eggs were detected in 240 subjects (24.0%; 95% CI, 21.5–26.7%). The paired patterns were IgG-positive/egg-positive in 185 participants (18.5%), IgG-positive/egg-negative in 146 (14.6%), IgG-negative/egg-positive in 55 (5.5%), and IgG-negative/egg-negative in 614 (61.4%). IgG positivity was detected in 77.1% of subjects with detected eggs and 19.2% of subjects without detected eggs (odds ratio, 14.15; 95% CI, 9.96–20.09; p < 0.001). The MVA Group and DRG ELISAs agreed for 990 of 1000 specimens (99.0%; 95% CI, 98.2–99.5%), with positive and negative agreements of 98.2% and 99.4%, respectively (κ = 0.98). Conclusions. Serology and copromicroscopy showed a high association, but they are not interchangeable. The paired-marker paradigm clarified concordant and discordant patterns while retaining IgG as a marker of past or ongoing immune exposure and stool eggs as markers of shedding at the time of sampling. High inter-assay agreement suggests analytical consistency within this serum panel, but does not imply diagnostic accuracy for active ascariasis.

12 August 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
TDTimur Davlyatshin
Timur Davlyatshin
ANAidar Namet
Aidar Namet
MOMukhit B. Orynbayev
Mukhit B. Orynbayev
KSKulyaisan Sultankulova
Kulyaisan Sultankulova
SBSabyrkhan Barmak
Sabyrkhan Barmak
BKBerik Khairullin
Berik Khairullin
Background: The aim of the present study was to develop and optimize an experimental ELISA test system for the detection of IgG antibodies to Toxocara canis and subsequently apply it for the assessment of human and canine exposure in Uralsk, Kazakhstan, within a One Health framework. Methods: A native somatic antigen of T. canis was fractionated by gel filtration, and the working fraction was selected by SDS-PAGE and pilot ELISA. The optimized test system was used for the analysis of sera of 1000 adult volunteers. Antibody avidity was determined in IgG-positive human specimens, and human seropositivity was evaluated for associations with demographic and questionnaire-derived variables. Serum samples from 100 stray dogs were tested by ELISA and fecal samples by copromicroscopy. Agreement with the commercial DRG ELISA was tested with 50 positive and 50 negative human serum samples. Results: The antigen fraction of 18–22 kDa showed the best separation between positive and negative sera. IgG antibodies against T. canis were detected in 116/1000 volunteers (11.6%). Seropositivity was 17.0% in the 2025 sample and 6.2% in the 2026 sample (odds ratio 3.10; 95% confidence interval 2.01–4.77; p < 0.001). No significant associations were found with sex, age, residence, or questionnaire-derived variables. Among seropositive volunteers, 28.4% had low-avidity, 26.7% intermediate-avidity, 29.3% intermediate/high-avidity and 15.5% high-avidity IgG. Overall, 78/100 of the stray dogs were copropositive, and 93/100 were seropositive. All copropositive dogs were seropositive, and 15 additional seropositive dogs were copronegative. Agreement with the DRG ELISA was 97.0% (Cohen’s κ = 0.94). Conclusions: The experimental ELISA allowed the assessment of T. canis exposure of humans and dogs. Seropositivity in humans in Uralsk showed exposure. High seropositivity in dogs and frequent egg shedding showed a substantial canine reservoir and a potential for environmental contamination. These results support integrated surveillance and control within a One Health context.